Cliniques du Sud-Luxembourg
- Address
- Rue des deportes 137, 6700 Arlon, Belgium
Cardiovascular Research
The department investigates atrial fibrillation and its impact on stroke risk, evaluating new oral anticoagulants such as milvexian and comparing them with established agents like apixaban. Studies also assess the benefit of long‑term anticoagulation versus antiplatelet therapy after catheter ablation.
- Anticoagulation strategies for stroke prevention
- Comparative effectiveness of novel oral anticoagulants
- Long‑term outcomes after catheter ablation
At Cliniques du Sud‑Luxembourg, participants receive comprehensive cardiovascular care while contributing to research that aims to reduce embolic events and improve survival.
Oncology Research
Clinical studies target ER+ HER2- breast cancer in older women, exploring whether adding chemotherapy or agents like everolimus to standard hormone therapy can lower the chance of relapse and extend disease‑free survival. Genomic grading guides personalized treatment decisions for high‑risk patients.
- Adjuvant chemotherapy effectiveness in elderly patients
- Everolimus combined with hormone therapy
- Genomic grade‑guided treatment strategies
The research team at the site integrates cutting‑edge oncology trials to improve outcomes for women facing a high risk of breast cancer recurrence.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Unicancer2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Cliniques du Sud-Luxembourg
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active-Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation | Janssen Cilag International | Phase III | Not Recruiting | Aug 2023 | — |
IMP list
lock Showing 1 of 13 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Apixaban | 2 | Unknown | 2023-08-23 | 2024-01-29 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.